nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Methylnaltrexone—CYP2D6—breast cancer	0.0015	0.0763	CrCbGaD
Nalbuphine—Buprenorphine—ABCG2—breast cancer	0.00141	0.0717	CrCbGaD
Nalbuphine—Naloxone—ESR1—breast cancer	0.00137	0.0698	CrCbGaD
Nalbuphine—Dihydrocodeine—CYP2D6—breast cancer	0.00128	0.0649	CrCbGaD
Nalbuphine—Hydromorphone—PTGS1—breast cancer	0.00119	0.0605	CrCbGaD
Nalbuphine—Oxymorphone—CYP2D6—breast cancer	0.00112	0.0569	CrCbGaD
Nalbuphine—Dihydrocodeine—CYP3A4—breast cancer	0.0011	0.0557	CrCbGaD
Nalbuphine—Oxymorphone—CYP3A4—breast cancer	0.000962	0.0488	CrCbGaD
Nalbuphine—Oxycodone—CYP2D6—breast cancer	0.000894	0.0454	CrCbGaD
Nalbuphine—Buprenorphine—CYP2D6—breast cancer	0.000824	0.0418	CrCbGaD
Nalbuphine—Hydromorphone—CYP2D6—breast cancer	0.000812	0.0412	CrCbGaD
Nalbuphine—Naltrexone—ABCB1—breast cancer	0.000801	0.0406	CrCbGaD
Nalbuphine—Oxycodone—CYP3A4—breast cancer	0.000767	0.0389	CrCbGaD
Nalbuphine—Buprenorphine—CYP3A4—breast cancer	0.000707	0.0359	CrCbGaD
Nalbuphine—Naloxone—CYP3A4—breast cancer	0.000702	0.0356	CrCbGaD
Nalbuphine—Hydromorphone—CYP3A4—breast cancer	0.000696	0.0353	CrCbGaD
Nalbuphine—Morphine—CYP2D6—breast cancer	0.00069	0.035	CrCbGaD
Nalbuphine—Naloxone—ALB—breast cancer	0.000612	0.0311	CrCbGaD
Nalbuphine—Morphine—CYP3A4—breast cancer	0.000592	0.0301	CrCbGaD
Nalbuphine—Gastrointestinal pain—Irinotecan—breast cancer	0.000589	0.00078	CcSEcCtD
Nalbuphine—Buprenorphine—ABCB1—breast cancer	0.000588	0.0299	CrCbGaD
Nalbuphine—Oedema—Paclitaxel—breast cancer	0.000587	0.000778	CcSEcCtD
Nalbuphine—Muscle spasms—Docetaxel—breast cancer	0.000586	0.000777	CcSEcCtD
Nalbuphine—Naloxone—ABCB1—breast cancer	0.000584	0.0296	CrCbGaD
Nalbuphine—Nausea—Goserelin—breast cancer	0.000579	0.000767	CcSEcCtD
Nalbuphine—Dysgeusia—Capecitabine—breast cancer	0.000578	0.000766	CcSEcCtD
Nalbuphine—Feeling abnormal—Gemcitabine—breast cancer	0.000578	0.000766	CcSEcCtD
Nalbuphine—Shock—Paclitaxel—breast cancer	0.000578	0.000765	CcSEcCtD
Nalbuphine—Dizziness—Vinorelbine—breast cancer	0.000577	0.000765	CcSEcCtD
Nalbuphine—Tachycardia—Paclitaxel—breast cancer	0.000573	0.000759	CcSEcCtD
Nalbuphine—Urticaria—Mitoxantrone—breast cancer	0.000572	0.000758	CcSEcCtD
Nalbuphine—Abdominal pain—Irinotecan—breast cancer	0.000569	0.000754	CcSEcCtD
Nalbuphine—Abdominal pain—Mitoxantrone—breast cancer	0.000569	0.000754	CcSEcCtD
Nalbuphine—Body temperature increased—Irinotecan—breast cancer	0.000569	0.000754	CcSEcCtD
Nalbuphine—Body temperature increased—Mitoxantrone—breast cancer	0.000569	0.000754	CcSEcCtD
Nalbuphine—Feeling abnormal—Fluorouracil—breast cancer	0.000568	0.000753	CcSEcCtD
Nalbuphine—Muscle spasms—Capecitabine—breast cancer	0.000568	0.000752	CcSEcCtD
Nalbuphine—Hyperhidrosis—Paclitaxel—breast cancer	0.000568	0.000752	CcSEcCtD
Nalbuphine—Depression—Methotrexate—breast cancer	0.000561	0.000743	CcSEcCtD
Nalbuphine—Vision blurred—Capecitabine—breast cancer	0.000556	0.000737	CcSEcCtD
Nalbuphine—Vomiting—Vinorelbine—breast cancer	0.000555	0.000735	CcSEcCtD
Nalbuphine—Body temperature increased—Gemcitabine—breast cancer	0.000554	0.000735	CcSEcCtD
Nalbuphine—Tremor—Capecitabine—breast cancer	0.000553	0.000733	CcSEcCtD
Nalbuphine—Dizziness—Thiotepa—breast cancer	0.000551	0.00073	CcSEcCtD
Nalbuphine—Rash—Vinorelbine—breast cancer	0.00055	0.000729	CcSEcCtD
Nalbuphine—Dermatitis—Vinorelbine—breast cancer	0.00055	0.000729	CcSEcCtD
Nalbuphine—Hypotension—Paclitaxel—breast cancer	0.000549	0.000727	CcSEcCtD
Nalbuphine—Urticaria—Fluorouracil—breast cancer	0.000548	0.000726	CcSEcCtD
Nalbuphine—Headache—Vinorelbine—breast cancer	0.000547	0.000725	CcSEcCtD
Nalbuphine—Syncope—Docetaxel—breast cancer	0.000547	0.000725	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—breast cancer	0.000546	0.000724	CcSEcCtD
Nalbuphine—Pollakiuria—Epirubicin—breast cancer	0.000545	0.000723	CcSEcCtD
Nalbuphine—Body temperature increased—Fluorouracil—breast cancer	0.000545	0.000722	CcSEcCtD
Nalbuphine—Loss of consciousness—Docetaxel—breast cancer	0.000536	0.00071	CcSEcCtD
Nalbuphine—Vertigo—Capecitabine—breast cancer	0.00053	0.000703	CcSEcCtD
Nalbuphine—Hypersensitivity—Mitoxantrone—breast cancer	0.00053	0.000703	CcSEcCtD
Nalbuphine—Hypersensitivity—Irinotecan—breast cancer	0.00053	0.000703	CcSEcCtD
Nalbuphine—Vomiting—Thiotepa—breast cancer	0.00053	0.000702	CcSEcCtD
Nalbuphine—Syncope—Capecitabine—breast cancer	0.000529	0.000702	CcSEcCtD
Nalbuphine—Convulsion—Docetaxel—breast cancer	0.000528	0.0007	CcSEcCtD
Nalbuphine—Paraesthesia—Paclitaxel—breast cancer	0.000527	0.000699	CcSEcCtD
Nalbuphine—Hypertension—Docetaxel—breast cancer	0.000526	0.000698	CcSEcCtD
Nalbuphine—Rash—Thiotepa—breast cancer	0.000526	0.000697	CcSEcCtD
Nalbuphine—Dermatitis—Thiotepa—breast cancer	0.000525	0.000696	CcSEcCtD
Nalbuphine—Dyspnoea—Paclitaxel—breast cancer	0.000523	0.000694	CcSEcCtD
Nalbuphine—Headache—Thiotepa—breast cancer	0.000522	0.000692	CcSEcCtD
Nalbuphine—Somnolence—Paclitaxel—breast cancer	0.000522	0.000692	CcSEcCtD
Nalbuphine—Loss of consciousness—Capecitabine—breast cancer	0.000519	0.000688	CcSEcCtD
Nalbuphine—Nausea—Vinorelbine—breast cancer	0.000519	0.000687	CcSEcCtD
Nalbuphine—Dyspepsia—Paclitaxel—breast cancer	0.000517	0.000685	CcSEcCtD
Nalbuphine—Asthenia—Mitoxantrone—breast cancer	0.000517	0.000684	CcSEcCtD
Nalbuphine—Asthenia—Irinotecan—breast cancer	0.000517	0.000684	CcSEcCtD
Nalbuphine—Hypertension—Capecitabine—breast cancer	0.00051	0.000675	CcSEcCtD
Nalbuphine—Hypersensitivity—Fluorouracil—breast cancer	0.000508	0.000673	CcSEcCtD
Nalbuphine—Dry mouth—Docetaxel—breast cancer	0.000508	0.000673	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—breast cancer	0.000505	0.000669	CcSEcCtD
Nalbuphine—Asthenia—Gemcitabine—breast cancer	0.000503	0.000667	CcSEcCtD
Nalbuphine—Confusional state—Docetaxel—breast cancer	0.000502	0.000665	CcSEcCtD
Nalbuphine—Anxiety—Capecitabine—breast cancer	0.000501	0.000664	CcSEcCtD
Nalbuphine—Oedema—Docetaxel—breast cancer	0.000498	0.000659	CcSEcCtD
Nalbuphine—Pruritus—Gemcitabine—breast cancer	0.000496	0.000657	CcSEcCtD
Nalbuphine—Nausea—Thiotepa—breast cancer	0.000495	0.000656	CcSEcCtD
Nalbuphine—Morphine—ABCB1—breast cancer	0.000493	0.025	CrCbGaD
Nalbuphine—Dry mouth—Capecitabine—breast cancer	0.000492	0.000651	CcSEcCtD
Nalbuphine—Shock—Docetaxel—breast cancer	0.00049	0.000649	CcSEcCtD
Nalbuphine—Pruritus—Fluorouracil—breast cancer	0.000488	0.000646	CcSEcCtD
Nalbuphine—Confusional state—Capecitabine—breast cancer	0.000486	0.000644	CcSEcCtD
Nalbuphine—Tachycardia—Docetaxel—breast cancer	0.000486	0.000644	CcSEcCtD
Nalbuphine—Feeling abnormal—Paclitaxel—breast cancer	0.000484	0.000641	CcSEcCtD
Nalbuphine—Oedema—Capecitabine—breast cancer	0.000482	0.000638	CcSEcCtD
Nalbuphine—Bradycardia—Epirubicin—breast cancer	0.000481	0.000637	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Paclitaxel—breast cancer	0.00048	0.000636	CcSEcCtD
Nalbuphine—Dizziness—Irinotecan—breast cancer	0.000476	0.000631	CcSEcCtD
Nalbuphine—Shock—Capecitabine—breast cancer	0.000474	0.000628	CcSEcCtD
Nalbuphine—Tachycardia—Capecitabine—breast cancer	0.00047	0.000623	CcSEcCtD
Nalbuphine—Hypoaesthesia—Epirubicin—breast cancer	0.00047	0.000623	CcSEcCtD
Nalbuphine—Urticaria—Paclitaxel—breast cancer	0.000466	0.000618	CcSEcCtD
Nalbuphine—Hyperhidrosis—Capecitabine—breast cancer	0.000466	0.000617	CcSEcCtD
Nalbuphine—Hypotension—Docetaxel—breast cancer	0.000465	0.000616	CcSEcCtD
Nalbuphine—Abdominal pain—Paclitaxel—breast cancer	0.000464	0.000615	CcSEcCtD
Nalbuphine—Body temperature increased—Paclitaxel—breast cancer	0.000464	0.000615	CcSEcCtD
Nalbuphine—Vomiting—Mitoxantrone—breast cancer	0.000458	0.000607	CcSEcCtD
Nalbuphine—Vomiting—Irinotecan—breast cancer	0.000458	0.000607	CcSEcCtD
Nalbuphine—Dizziness—Fluorouracil—breast cancer	0.000456	0.000604	CcSEcCtD
Nalbuphine—Rash—Irinotecan—breast cancer	0.000454	0.000601	CcSEcCtD
Nalbuphine—Rash—Mitoxantrone—breast cancer	0.000454	0.000601	CcSEcCtD
Nalbuphine—Dermatitis—Mitoxantrone—breast cancer	0.000454	0.000601	CcSEcCtD
Nalbuphine—Dermatitis—Irinotecan—breast cancer	0.000454	0.000601	CcSEcCtD
Nalbuphine—Headache—Mitoxantrone—breast cancer	0.000451	0.000598	CcSEcCtD
Nalbuphine—Headache—Irinotecan—breast cancer	0.000451	0.000598	CcSEcCtD
Nalbuphine—Hypotension—Capecitabine—breast cancer	0.00045	0.000597	CcSEcCtD
Nalbuphine—Paraesthesia—Docetaxel—breast cancer	0.000447	0.000592	CcSEcCtD
Nalbuphine—Vomiting—Gemcitabine—breast cancer	0.000446	0.000591	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—breast cancer	0.000445	0.00059	CcSEcCtD
Nalbuphine—Dyspnoea—Docetaxel—breast cancer	0.000444	0.000588	CcSEcCtD
Nalbuphine—Somnolence—Docetaxel—breast cancer	0.000442	0.000586	CcSEcCtD
Nalbuphine—Rash—Gemcitabine—breast cancer	0.000442	0.000586	CcSEcCtD
Nalbuphine—Dermatitis—Gemcitabine—breast cancer	0.000442	0.000585	CcSEcCtD
Nalbuphine—Erythema—Methotrexate—breast cancer	0.00044	0.000582	CcSEcCtD
Nalbuphine—Headache—Gemcitabine—breast cancer	0.000439	0.000582	CcSEcCtD
Nalbuphine—Flushing—Epirubicin—breast cancer	0.000439	0.000581	CcSEcCtD
Nalbuphine—Vomiting—Fluorouracil—breast cancer	0.000438	0.000581	CcSEcCtD
Nalbuphine—Dyspepsia—Docetaxel—breast cancer	0.000438	0.00058	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—breast cancer	0.000435	0.000576	CcSEcCtD
Nalbuphine—Rash—Fluorouracil—breast cancer	0.000435	0.000576	CcSEcCtD
Nalbuphine—Dermatitis—Fluorouracil—breast cancer	0.000434	0.000576	CcSEcCtD
Nalbuphine—Paraesthesia—Capecitabine—breast cancer	0.000433	0.000573	CcSEcCtD
Nalbuphine—Hypersensitivity—Paclitaxel—breast cancer	0.000433	0.000573	CcSEcCtD
Nalbuphine—Headache—Fluorouracil—breast cancer	0.000432	0.000572	CcSEcCtD
Nalbuphine—Dysgeusia—Methotrexate—breast cancer	0.00043	0.00057	CcSEcCtD
Nalbuphine—Dyspnoea—Capecitabine—breast cancer	0.00043	0.000569	CcSEcCtD
Nalbuphine—Nausea—Mitoxantrone—breast cancer	0.000428	0.000567	CcSEcCtD
Nalbuphine—Nausea—Irinotecan—breast cancer	0.000428	0.000567	CcSEcCtD
Nalbuphine—Dyspepsia—Capecitabine—breast cancer	0.000424	0.000562	CcSEcCtD
Nalbuphine—Asthenia—Paclitaxel—breast cancer	0.000421	0.000558	CcSEcCtD
Nalbuphine—Nausea—Gemcitabine—breast cancer	0.000417	0.000552	CcSEcCtD
Nalbuphine—Pruritus—Paclitaxel—breast cancer	0.000415	0.00055	CcSEcCtD
Nalbuphine—Vision blurred—Methotrexate—breast cancer	0.000414	0.000549	CcSEcCtD
Nalbuphine—Erythema—Epirubicin—breast cancer	0.000411	0.000545	CcSEcCtD
Nalbuphine—Feeling abnormal—Docetaxel—breast cancer	0.00041	0.000543	CcSEcCtD
Nalbuphine—Nausea—Fluorouracil—breast cancer	0.00041	0.000543	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Docetaxel—breast cancer	0.000407	0.000539	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—breast cancer	0.000406	0.000538	CcSEcCtD
Nalbuphine—Tension—Epirubicin—breast cancer	0.000404	0.000535	CcSEcCtD
Nalbuphine—Dysgeusia—Epirubicin—breast cancer	0.000403	0.000534	CcSEcCtD
Nalbuphine—Nervousness—Epirubicin—breast cancer	0.000399	0.000529	CcSEcCtD
Nalbuphine—Feeling abnormal—Capecitabine—breast cancer	0.000397	0.000526	CcSEcCtD
Nalbuphine—Muscle spasms—Epirubicin—breast cancer	0.000395	0.000524	CcSEcCtD
Nalbuphine—Vertigo—Methotrexate—breast cancer	0.000395	0.000523	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Capecitabine—breast cancer	0.000394	0.000522	CcSEcCtD
Nalbuphine—Abdominal pain—Docetaxel—breast cancer	0.000393	0.000521	CcSEcCtD
Nalbuphine—Body temperature increased—Docetaxel—breast cancer	0.000393	0.000521	CcSEcCtD
Nalbuphine—Dizziness—Paclitaxel—breast cancer	0.000388	0.000514	CcSEcCtD
Nalbuphine—Vision blurred—Epirubicin—breast cancer	0.000388	0.000514	CcSEcCtD
Nalbuphine—Urticaria—Capecitabine—breast cancer	0.000383	0.000507	CcSEcCtD
Nalbuphine—Abdominal pain—Capecitabine—breast cancer	0.000381	0.000505	CcSEcCtD
Nalbuphine—Body temperature increased—Capecitabine—breast cancer	0.000381	0.000505	CcSEcCtD
Nalbuphine—Convulsion—Methotrexate—breast cancer	0.000381	0.000505	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—breast cancer	0.000381	0.000504	CcSEcCtD
Nalbuphine—Agitation—Epirubicin—breast cancer	0.000378	0.000501	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—breast cancer	0.000373	0.000495	CcSEcCtD
Nalbuphine—Vomiting—Paclitaxel—breast cancer	0.000373	0.000495	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—breast cancer	0.000373	0.000494	CcSEcCtD
Nalbuphine—Rash—Paclitaxel—breast cancer	0.00037	0.000491	CcSEcCtD
Nalbuphine—Dermatitis—Paclitaxel—breast cancer	0.00037	0.00049	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—breast cancer	0.00037	0.00049	CcSEcCtD
Nalbuphine—Vertigo—Epirubicin—breast cancer	0.00037	0.00049	CcSEcCtD
Nalbuphine—Syncope—Epirubicin—breast cancer	0.000369	0.000489	CcSEcCtD
Nalbuphine—Headache—Paclitaxel—breast cancer	0.000368	0.000487	CcSEcCtD
Nalbuphine—Hypersensitivity—Docetaxel—breast cancer	0.000367	0.000486	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—breast cancer	0.000366	0.000485	CcSEcCtD
Nalbuphine—Confusional state—Methotrexate—breast cancer	0.000362	0.000479	CcSEcCtD
Nalbuphine—Loss of consciousness—Epirubicin—breast cancer	0.000362	0.000479	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—breast cancer	0.000359	0.000475	CcSEcCtD
Nalbuphine—Asthenia—Docetaxel—breast cancer	0.000357	0.000473	CcSEcCtD
Nalbuphine—Convulsion—Epirubicin—breast cancer	0.000356	0.000472	CcSEcCtD
Nalbuphine—Hypertension—Epirubicin—breast cancer	0.000355	0.000471	CcSEcCtD
Nalbuphine—Hypersensitivity—Capecitabine—breast cancer	0.000355	0.00047	CcSEcCtD
Nalbuphine—Pruritus—Docetaxel—breast cancer	0.000352	0.000467	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—breast cancer	0.00035	0.000463	CcSEcCtD
Nalbuphine—Anxiety—Epirubicin—breast cancer	0.000349	0.000462	CcSEcCtD
Nalbuphine—Nausea—Paclitaxel—breast cancer	0.000349	0.000462	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methotrexate—breast cancer	0.000347	0.000459	CcSEcCtD
Nalbuphine—Asthenia—Capecitabine—breast cancer	0.000346	0.000458	CcSEcCtD
Nalbuphine—Dry mouth—Epirubicin—breast cancer	0.000342	0.000454	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—breast cancer	0.000342	0.000453	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—breast cancer	0.000341	0.000452	CcSEcCtD
Nalbuphine—Pruritus—Capecitabine—breast cancer	0.000341	0.000452	CcSEcCtD
Nalbuphine—Confusional state—Epirubicin—breast cancer	0.000338	0.000448	CcSEcCtD
Nalbuphine—Oedema—Epirubicin—breast cancer	0.000336	0.000445	CcSEcCtD
Nalbuphine—Hypotension—Methotrexate—breast cancer	0.000335	0.000444	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—breast cancer	0.000334	0.000443	CcSEcCtD
Nalbuphine—Shock—Epirubicin—breast cancer	0.00033	0.000438	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—breast cancer	0.00033	0.000437	CcSEcCtD
Nalbuphine—Dizziness—Docetaxel—breast cancer	0.000329	0.000436	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—breast cancer	0.000329	0.000435	CcSEcCtD
Nalbuphine—Tachycardia—Epirubicin—breast cancer	0.000328	0.000434	CcSEcCtD
Nalbuphine—Hyperhidrosis—Epirubicin—breast cancer	0.000325	0.00043	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—breast cancer	0.000323	0.000428	CcSEcCtD
Nalbuphine—Paraesthesia—Methotrexate—breast cancer	0.000322	0.000427	CcSEcCtD
Nalbuphine—Dyspnoea—Methotrexate—breast cancer	0.00032	0.000424	CcSEcCtD
Nalbuphine—Somnolence—Methotrexate—breast cancer	0.000319	0.000423	CcSEcCtD
Nalbuphine—Dizziness—Capecitabine—breast cancer	0.000319	0.000422	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—breast cancer	0.000317	0.00042	CcSEcCtD
Nalbuphine—Vomiting—Docetaxel—breast cancer	0.000316	0.000419	CcSEcCtD
Nalbuphine—Dyspepsia—Methotrexate—breast cancer	0.000316	0.000418	CcSEcCtD
Nalbuphine—Rash—Docetaxel—breast cancer	0.000314	0.000416	CcSEcCtD
Nalbuphine—Hypotension—Epirubicin—breast cancer	0.000314	0.000416	CcSEcCtD
Nalbuphine—Dermatitis—Docetaxel—breast cancer	0.000314	0.000415	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—breast cancer	0.000313	0.000415	CcSEcCtD
Nalbuphine—Headache—Docetaxel—breast cancer	0.000312	0.000413	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—breast cancer	0.000311	0.000412	CcSEcCtD
Nalbuphine—Vomiting—Capecitabine—breast cancer	0.000306	0.000406	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—breast cancer	0.000306	0.000405	CcSEcCtD
Nalbuphine—Rash—Capecitabine—breast cancer	0.000304	0.000403	CcSEcCtD
Nalbuphine—Dermatitis—Capecitabine—breast cancer	0.000304	0.000402	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—breast cancer	0.000303	0.000402	CcSEcCtD
Nalbuphine—Headache—Capecitabine—breast cancer	0.000302	0.0004	CcSEcCtD
Nalbuphine—Paraesthesia—Epirubicin—breast cancer	0.000301	0.000399	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—breast cancer	0.0003	0.000398	CcSEcCtD
Nalbuphine—Dyspnoea—Epirubicin—breast cancer	0.000299	0.000397	CcSEcCtD
Nalbuphine—Somnolence—Epirubicin—breast cancer	0.000298	0.000395	CcSEcCtD
Nalbuphine—Nausea—Docetaxel—breast cancer	0.000296	0.000392	CcSEcCtD
Nalbuphine—Feeling abnormal—Methotrexate—breast cancer	0.000296	0.000392	CcSEcCtD
Nalbuphine—Dyspepsia—Epirubicin—breast cancer	0.000295	0.000392	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methotrexate—breast cancer	0.000293	0.000389	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—breast cancer	0.00029	0.000385	CcSEcCtD
Nalbuphine—Nausea—Capecitabine—breast cancer	0.000286	0.000379	CcSEcCtD
Nalbuphine—Urticaria—Methotrexate—breast cancer	0.000285	0.000378	CcSEcCtD
Nalbuphine—Abdominal pain—Methotrexate—breast cancer	0.000284	0.000376	CcSEcCtD
Nalbuphine—Body temperature increased—Methotrexate—breast cancer	0.000284	0.000376	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—breast cancer	0.000279	0.00037	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—breast cancer	0.000277	0.000367	CcSEcCtD
Nalbuphine—Feeling abnormal—Epirubicin—breast cancer	0.000277	0.000367	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—breast cancer	0.000276	0.000366	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Epirubicin—breast cancer	0.000274	0.000364	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—breast cancer	0.000273	0.000362	CcSEcCtD
Nalbuphine—Urticaria—Epirubicin—breast cancer	0.000267	0.000353	CcSEcCtD
Nalbuphine—Body temperature increased—Epirubicin—breast cancer	0.000265	0.000352	CcSEcCtD
Nalbuphine—Abdominal pain—Epirubicin—breast cancer	0.000265	0.000352	CcSEcCtD
Nalbuphine—Hypersensitivity—Methotrexate—breast cancer	0.000264	0.00035	CcSEcCtD
Nalbuphine—Asthenia—Methotrexate—breast cancer	0.000257	0.000341	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—breast cancer	0.000256	0.000339	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—breast cancer	0.000254	0.000337	CcSEcCtD
Nalbuphine—Pruritus—Methotrexate—breast cancer	0.000254	0.000336	CcSEcCtD
Nalbuphine—Hypersensitivity—Epirubicin—breast cancer	0.000247	0.000328	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—breast cancer	0.000247	0.000327	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—breast cancer	0.000246	0.000325	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—breast cancer	0.000246	0.000325	CcSEcCtD
Nalbuphine—Asthenia—Epirubicin—breast cancer	0.000241	0.000319	CcSEcCtD
Nalbuphine—Pruritus—Epirubicin—breast cancer	0.000237	0.000315	CcSEcCtD
Nalbuphine—Dizziness—Methotrexate—breast cancer	0.000237	0.000314	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—breast cancer	0.000229	0.000303	CcSEcCtD
Nalbuphine—Vomiting—Methotrexate—breast cancer	0.000228	0.000302	CcSEcCtD
Nalbuphine—Rash—Methotrexate—breast cancer	0.000226	0.0003	CcSEcCtD
Nalbuphine—Dermatitis—Methotrexate—breast cancer	0.000226	0.000299	CcSEcCtD
Nalbuphine—Headache—Methotrexate—breast cancer	0.000225	0.000298	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—breast cancer	0.000223	0.000295	CcSEcCtD
Nalbuphine—Dizziness—Epirubicin—breast cancer	0.000222	0.000294	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—breast cancer	0.00022	0.000291	CcSEcCtD
Nalbuphine—Vomiting—Epirubicin—breast cancer	0.000213	0.000283	CcSEcCtD
Nalbuphine—Nausea—Methotrexate—breast cancer	0.000213	0.000282	CcSEcCtD
Nalbuphine—Rash—Epirubicin—breast cancer	0.000212	0.00028	CcSEcCtD
Nalbuphine—Dermatitis—Epirubicin—breast cancer	0.000211	0.00028	CcSEcCtD
Nalbuphine—Headache—Epirubicin—breast cancer	0.00021	0.000279	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—breast cancer	0.000205	0.000272	CcSEcCtD
Nalbuphine—Nausea—Epirubicin—breast cancer	0.000199	0.000264	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—breast cancer	0.000197	0.000262	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—breast cancer	0.000196	0.000259	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—breast cancer	0.000196	0.000259	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—breast cancer	0.000195	0.000258	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—breast cancer	0.000184	0.000244	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—E2F1—breast cancer	6.74e-05	0.000299	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CB—breast cancer	6.71e-05	0.000297	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PAK1—breast cancer	6.69e-05	0.000296	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFBR2—breast cancer	6.65e-05	0.000295	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TCF7L2—breast cancer	6.57e-05	0.000291	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ITPR1—breast cancer	6.54e-05	0.00029	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT2—breast cancer	6.54e-05	0.00029	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ERBB4—breast cancer	6.5e-05	0.000288	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP3—breast cancer	6.5e-05	0.000288	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT5A—breast cancer	6.5e-05	0.000288	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CG—breast cancer	6.49e-05	0.000288	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CB—breast cancer	6.48e-05	0.000287	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SPP1—breast cancer	6.48e-05	0.000287	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL8—breast cancer	6.45e-05	0.000286	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ERBB3—breast cancer	6.41e-05	0.000284	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGFR2—breast cancer	6.4e-05	0.000284	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HSP90AA1—breast cancer	6.33e-05	0.000281	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOTCH2—breast cancer	6.33e-05	0.000281	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SMAD4—breast cancer	6.29e-05	0.000279	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CD—breast cancer	6.28e-05	0.000278	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1R—breast cancer	6.25e-05	0.000277	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL8—breast cancer	6.23e-05	0.000276	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL2—breast cancer	6.16e-05	0.000273	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AGTR1—breast cancer	6.16e-05	0.000273	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRL—breast cancer	6.16e-05	0.000273	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HES1—breast cancer	6.14e-05	0.000272	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TERT—breast cancer	6.14e-05	0.000272	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NCOR1—breast cancer	6.11e-05	0.000271	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PLA2G4A—breast cancer	6.11e-05	0.000271	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STK11—breast cancer	6.07e-05	0.000269	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADAM10—breast cancer	6.07e-05	0.000269	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CSF2—breast cancer	6.04e-05	0.000268	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGF1—breast cancer	6.04e-05	0.000268	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—RAF1—breast cancer	6.03e-05	0.000267	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PLG—breast cancer	6e-05	0.000266	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NRG1—breast cancer	6e-05	0.000266	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGFR1—breast cancer	5.96e-05	0.000264	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—H2AFX—breast cancer	5.95e-05	0.000264	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL2—breast cancer	5.95e-05	0.000264	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT2—breast cancer	5.94e-05	0.000263	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—E2F1—breast cancer	5.91e-05	0.000262	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGF10—breast cancer	5.91e-05	0.000262	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CB—breast cancer	5.88e-05	0.000261	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HIF1A—breast cancer	5.87e-05	0.00026	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LEP—breast cancer	5.73e-05	0.000254	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CD—breast cancer	5.7e-05	0.000253	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PDGFA—breast cancer	5.7e-05	0.000253	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CAV1—breast cancer	5.68e-05	0.000252	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SPP1—breast cancer	5.68e-05	0.000252	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL8—breast cancer	5.65e-05	0.000251	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFBR2—breast cancer	5.62e-05	0.000249	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ERBB3—breast cancer	5.62e-05	0.000249	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KDR—breast cancer	5.62e-05	0.000249	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGFR2—breast cancer	5.61e-05	0.000249	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ITPR1—breast cancer	5.53e-05	0.000245	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT5A—breast cancer	5.49e-05	0.000243	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ERBB4—breast cancer	5.49e-05	0.000243	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP3—breast cancer	5.49e-05	0.000243	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CB—breast cancer	5.48e-05	0.000243	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ESR1—breast cancer	5.47e-05	0.000243	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FN1—breast cancer	5.41e-05	0.00024	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL2—breast cancer	5.4e-05	0.00024	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TERT—breast cancer	5.38e-05	0.000239	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NFKBIA—breast cancer	5.34e-05	0.000237	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SMAD4—breast cancer	5.32e-05	0.000236	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOTCH1—breast cancer	5.29e-05	0.000234	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1R—breast cancer	5.29e-05	0.000234	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL8—breast cancer	5.26e-05	0.000233	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGFR1—breast cancer	5.23e-05	0.000232	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HES1—breast cancer	5.19e-05	0.00023	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CG—breast cancer	5.17e-05	0.000229	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APC—breast cancer	5.17e-05	0.000229	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KIT—breast cancer	5.17e-05	0.000229	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NCOR1—breast cancer	5.16e-05	0.000229	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PLA2G4A—breast cancer	5.16e-05	0.000229	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HIF1A—breast cancer	5.15e-05	0.000228	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGF—breast cancer	5.11e-05	0.000227	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGF1—breast cancer	5.1e-05	0.000226	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CSF2—breast cancer	5.1e-05	0.000226	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—RAF1—breast cancer	5.09e-05	0.000226	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NRG1—breast cancer	5.07e-05	0.000225	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—H2AFX—breast cancer	5.03e-05	0.000223	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL2—breast cancer	5.03e-05	0.000223	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LEP—breast cancer	5.03e-05	0.000223	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—E2F1—breast cancer	5e-05	0.000221	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CAV1—breast cancer	4.98e-05	0.000221	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CB—breast cancer	4.97e-05	0.00022	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAPK3—breast cancer	4.95e-05	0.00022	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KDR—breast cancer	4.92e-05	0.000218	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—BRAF—breast cancer	4.86e-05	0.000216	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SPP1—breast cancer	4.8e-05	0.000213	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ESR1—breast cancer	4.8e-05	0.000213	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL8—breast cancer	4.78e-05	0.000212	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ERBB3—breast cancer	4.75e-05	0.00021	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGFR2—breast cancer	4.74e-05	0.00021	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FN1—breast cancer	4.74e-05	0.00021	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1—breast cancer	4.74e-05	0.00021	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT2—breast cancer	4.73e-05	0.00021	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—EGFR—breast cancer	4.71e-05	0.000209	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NFKBIA—breast cancer	4.68e-05	0.000208	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOTCH1—breast cancer	4.64e-05	0.000206	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL2—breast cancer	4.57e-05	0.000202	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TERT—breast cancer	4.55e-05	0.000202	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CD—breast cancer	4.55e-05	0.000202	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CG—breast cancer	4.54e-05	0.000201	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APC—breast cancer	4.54e-05	0.000201	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KIT—breast cancer	4.54e-05	0.000201	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CA—breast cancer	4.5e-05	0.0002	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SERPINE1—breast cancer	4.5e-05	0.000199	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGF—breast cancer	4.48e-05	0.000199	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—KRAS—breast cancer	4.45e-05	0.000197	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGFR1—breast cancer	4.42e-05	0.000196	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HIF1A—breast cancer	4.35e-05	0.000193	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAPK3—breast cancer	4.34e-05	0.000193	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOS3—breast cancer	4.29e-05	0.00019	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—BRAF—breast cancer	4.26e-05	0.000189	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LEP—breast cancer	4.25e-05	0.000188	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CAV1—breast cancer	4.21e-05	0.000187	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KDR—breast cancer	4.16e-05	0.000184	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1—breast cancer	4.15e-05	0.000184	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT2—breast cancer	4.15e-05	0.000184	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—EGFR—breast cancer	4.13e-05	0.000183	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CA—breast cancer	4.09e-05	0.000181	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MDM2—breast cancer	4.07e-05	0.000181	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RAF1—breast cancer	4.06e-05	0.00018	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ESR1—breast cancer	4.06e-05	0.00018	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RELA—breast cancer	4.04e-05	0.000179	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ERBB2—breast cancer	4.02e-05	0.000178	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FN1—breast cancer	4.01e-05	0.000178	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CD—breast cancer	3.99e-05	0.000177	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MTOR—breast cancer	3.96e-05	0.000176	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CB—breast cancer	3.96e-05	0.000176	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NFKBIA—breast cancer	3.96e-05	0.000175	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CA—breast cancer	3.95e-05	0.000175	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SERPINE1—breast cancer	3.94e-05	0.000175	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOTCH1—breast cancer	3.92e-05	0.000174	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—KRAS—breast cancer	3.9e-05	0.000173	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KIT—breast cancer	3.83e-05	0.00017	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APC—breast cancer	3.83e-05	0.00017	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CG—breast cancer	3.83e-05	0.00017	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL8—breast cancer	3.81e-05	0.000169	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGF—breast cancer	3.79e-05	0.000168	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—HRAS—breast cancer	3.78e-05	0.000168	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOS3—breast cancer	3.77e-05	0.000167	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN1B—breast cancer	3.72e-05	0.000165	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT1—breast cancer	3.68e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAPK3—breast cancer	3.67e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CASP3—breast cancer	3.65e-05	0.000162	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL2—breast cancer	3.64e-05	0.000161	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—breast cancer	3.62e-05	0.000161	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—BRAF—breast cancer	3.6e-05	0.00016	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CA—breast cancer	3.59e-05	0.000159	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MDM2—breast cancer	3.57e-05	0.000158	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RAF1—breast cancer	3.56e-05	0.000158	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCND1—breast cancer	3.55e-05	0.000157	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RELA—breast cancer	3.54e-05	0.000157	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JUN—breast cancer	3.54e-05	0.000157	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ERBB2—breast cancer	3.52e-05	0.000156	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CTNNB1—breast cancer	3.51e-05	0.000156	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1—breast cancer	3.51e-05	0.000156	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT2—breast cancer	3.51e-05	0.000155	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—EGFR—breast cancer	3.49e-05	0.000155	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MTOR—breast cancer	3.48e-05	0.000154	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CB—breast cancer	3.48e-05	0.000154	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP9—breast cancer	3.45e-05	0.000153	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN1A—breast cancer	3.43e-05	0.000152	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTEN—breast cancer	3.43e-05	0.000152	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CD—breast cancer	3.37e-05	0.000149	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK8—breast cancer	3.35e-05	0.000149	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT1—breast cancer	3.34e-05	0.000148	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL8—breast cancer	3.34e-05	0.000148	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CA—breast cancer	3.34e-05	0.000148	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SERPINE1—breast cancer	3.33e-05	0.000148	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—HRAS—breast cancer	3.32e-05	0.000147	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—KRAS—breast cancer	3.3e-05	0.000146	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN1B—breast cancer	3.26e-05	0.000145	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT1—breast cancer	3.23e-05	0.000143	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CASP3—breast cancer	3.2e-05	0.000142	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL2—breast cancer	3.19e-05	0.000141	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOS3—breast cancer	3.18e-05	0.000141	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SRC—breast cancer	3.18e-05	0.000141	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—breast cancer	3.18e-05	0.000141	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCND1—breast cancer	3.11e-05	0.000138	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JUN—breast cancer	3.11e-05	0.000138	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VEGFA—breast cancer	3.09e-05	0.000137	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CTNNB1—breast cancer	3.08e-05	0.000137	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—breast cancer	3.06e-05	0.000136	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CA—breast cancer	3.03e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP9—breast cancer	3.02e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MDM2—breast cancer	3.02e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN1A—breast cancer	3.01e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RAF1—breast cancer	3.01e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTEN—breast cancer	3e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RELA—breast cancer	3e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ERBB2—breast cancer	2.98e-05	0.000132	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK8—breast cancer	2.94e-05	0.00013	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MTOR—breast cancer	2.94e-05	0.00013	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CB—breast cancer	2.94e-05	0.00013	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT1—breast cancer	2.93e-05	0.00013	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK3—breast cancer	2.93e-05	0.00013	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MYC—breast cancer	2.85e-05	0.000126	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFB1—breast cancer	2.84e-05	0.000126	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL8—breast cancer	2.82e-05	0.000125	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—HRAS—breast cancer	2.8e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SRC—breast cancer	2.79e-05	0.000123	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGFR—breast cancer	2.78e-05	0.000123	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN1B—breast cancer	2.76e-05	0.000122	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT1—breast cancer	2.73e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VEGFA—breast cancer	2.71e-05	0.00012	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CASP3—breast cancer	2.7e-05	0.00012	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL2—breast cancer	2.7e-05	0.00012	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—breast cancer	2.69e-05	0.000119	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—breast cancer	2.68e-05	0.000119	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KRAS—breast cancer	2.63e-05	0.000117	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCND1—breast cancer	2.63e-05	0.000117	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JUN—breast cancer	2.62e-05	0.000116	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CTNNB1—breast cancer	2.6e-05	0.000115	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK3—breast cancer	2.57e-05	0.000114	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP9—breast cancer	2.55e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN1A—breast cancer	2.54e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTEN—breast cancer	2.54e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MYC—breast cancer	2.5e-05	0.000111	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFB1—breast cancer	2.49e-05	0.00011	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK8—breast cancer	2.48e-05	0.00011	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT1—breast cancer	2.48e-05	0.00011	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGFR—breast cancer	2.44e-05	0.000108	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CA—breast cancer	2.42e-05	0.000107	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SRC—breast cancer	2.35e-05	0.000104	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TP53—breast cancer	2.34e-05	0.000104	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KRAS—breast cancer	2.31e-05	0.000102	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFA—breast cancer	2.29e-05	0.000102	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—breast cancer	2.27e-05	0.000101	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HRAS—breast cancer	2.24e-05	9.91e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK3—breast cancer	2.17e-05	9.61e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—breast cancer	2.14e-05	9.48e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CA—breast cancer	2.12e-05	9.39e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MYC—breast cancer	2.11e-05	9.35e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFB1—breast cancer	2.1e-05	9.33e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGFR—breast cancer	2.06e-05	9.15e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TP53—breast cancer	2.05e-05	9.09e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT1—breast cancer	1.97e-05	8.75e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HRAS—breast cancer	1.96e-05	8.69e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KRAS—breast cancer	1.95e-05	8.64e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—breast cancer	1.88e-05	8.32e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CA—breast cancer	1.79e-05	7.94e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TP53—breast cancer	1.73e-05	7.68e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT1—breast cancer	1.73e-05	7.67e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HRAS—breast cancer	1.66e-05	7.34e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—breast cancer	1.59e-05	7.03e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT1—breast cancer	1.46e-05	6.48e-05	CbGpPWpGaD
